1 - 25 of 403
Number of results to display per page
TitleCreatorRelation Is Part Of
1 Should I Have Teprotumumab or Surgery?Alison V. Crum, MDNANOS Annual Meeting 2023: Ophthalmic Surgery in the Neuro-Ophthalmic Patient: https://novel.utah.edu/collection/NAM/toc/
2 Should I Have Teprotumumab or Surgery?Alison V. Crum, MDNANOS Annual Meeting 2023: Ophthalmic Surgery in the Neuro-Ophthalmic Patient
3 Thyroid Eye Disease - Pilot StudyFrisard; Nicholas E; Rowland, Anne P; Acierno, Marie D; Cockerham, Kimberly P; Hariri, Adham AlNANOS 2013: Poster Presentations
4 Ocular Motility in Thyroid Eye Disease Evaluation and SurgerySteven E. Feldon, MD, University of Rochester Medical CenterNANOS 2010: IV Thyroid Eye Disease Update
5 Ocular Motility in Thyroid Eye Disease Evaluation and SurgerySteven E. Feldon, MD, University of Rochester Medical CenterNANOS 2010: IV Thyroid Eye Disease Update
6 Efficacy of Restasis(R) (0.05% Cyclosporine A) Ophthalmic Emulsion in Patients with Thyroid Eye Disease (TED)Crow, Lauren; Cockerham, Kimberly; Li, JingNANOS 2007: Poster Presentations
7 Thyroid Eye Disease in Young Patients Compared with OlderHuna-Baron, Ruth; Katz, Gaby; Leiba, Hana; Hadas, Biatrix; Simon, Guy J BenNANOS 2010: Poster Presentations
8 Development of Increased Vertical Fusional Amplitudes in Patients with Thyroid Eye DiseaseBreker, Dane; Cornblath, WayneNANOS 2012: Poster Presentations
9 Quantifying Success of Radiation Therapy for Thyroid Optic NeuropathyZak, Rochelle S; Winterkorn, J; Rush, SNANOS 1996: Scientific Platform Presentations (Session 1)
10 Orbital Fibroblasts From Thyroid Eye Disease Patients Differ In Proliferative And Adipogenic Responses Depending On Disease Sub-typeAjay E. Kuriyan, MD, University of Rochester Medical Center; Collynn F. Woeller, MD, University of Rochester Medical Center; Charles W. O'Loughlin, MD, University of Rochester Eye Institute; Richard P. Phipps, MD, University of Rochester Eye Institute; Steven E. Feldon, MD, University of Rochester M...NANOS 2014: Scientific Platform Presentations (Session 2)
11 Orbital Fibroblasts From Thyroid Eye Disease Patients Differ In Proliferative And Adipogenic Responses Depending On Disease Sub-typeAjay E. Kuriyan, MD, University of Rochester Medical Center; Collynn F. Woeller, MD, University of Rochester Medical Center; Charles W. O'Loughlin, MD, University of Rochester Eye Institute; Richard P. Phipps, MD, University of Rochester Eye Institute; Steven E. Feldon, MD, University of Rochester M...NANOS 2014: Scientific Platform Presentations (Session 2)
12 Adult with Acquired Oblique Diplopia: Do I Image? Do I Operate? (PDF)Hilda Capó, MDNANOS Annual Meeting 2020: Strabismus: Image? Operate?
13 Orbital Ultrasound as the Primary Imaging Modality in Patients with Ocular Misalignment and Suspected Thyroid Eye DiseaseVolpe, Nicholas J; Sbarbaro, james; Gendron, EK; Liu, Grant; Galetta, Steven; Balcer, LauraNANOS 2003: Scientific Platforms Presentations II
14 Objective Markers for Thyroid Eye Disease (TED) Activity, Severity 387 and ProgressionKimberly Cockerham, MD, FACSNANOS 2010: IV Thyroid Eye Disease Update
15 Objective Markers for Thyroid Eye Disease (TED) Activity, Severity 387 and ProgressionKimberly Cockerham, MD, FACSNANOS 2010: IV Thyroid Eye Disease Update
16 Eye Movement Fatigibility in Myasthenia Gravis Observed by Video-oculographyJu-Hee Chae, Hyun-June Shin, Sun-Young OhNAM 2019: Poster Session II: Scientific Advancements in Neuro-Ophthalmology
17 Checkpoint inhibitor associated orbital inflammation masquerading as ocular myasthenia gravis and thyroid eye diseaseMarisa Tieger, Eric Gaier, Sashank Prasad, Michael YoonNAM 2019: Poster Session I: Clinical Highlights in Neuro-Ophthalmology
18 Sustainability of Teprotumumab Efficacy in Thyroid Eye DiseasePrem S. Subramanian, Saba Sile, Robert Holt, Raymond DouglasNANOS Annual Meeting 2022: Scientific Platform III
19 Eyetracking in Pediatric Multiple SclerosisAndrew Yousef, Michael Deveruex, Pierre-Antoine Gourraud, Soren Jonzzon, Leena Suleiman, Janet Chong, Emmanuelle Waubant, Ari Green, Jennifer GravesNANOS 2018: Poster Presentations
20 Compressive Optic Neuropathy? - A Case of Thyroid-associated Optic Neuropathy without Crowding Orbital ApexKo-Jo LinNANOS 2018: Poster Presentations
21 All Signs Point to Giant Cell ArteritisDmitry Balian, Brooke Johnson, Peter MacIntoshNANOS Annual Meeting 2020: Poster Session I: Clinical Highlights
22 Immunology of Thyroid Eye DiseaseFeldon, Steven E; Phipps, RichardNANOS 2007: Immunological Diseases in Neuro-Ophthalmology
23 Teprotumumab Efficacy in Retreatment and Longer-Term Thyroid Eye Disease: OPTIC-X Study ResultsRaymond Douglas, Saba Sile, Terry Smith, George KahalyNANOS Annual Meeting 2021: Scientific Platform Session I
24 Extraocular Muscle Enlargement in Thyroid Eye Disease Using Volumetric AnalysisKristen Park; Joyce Wen; Joy Li; Shirley Li; Johnny Lee; Kimberly Gokoffski; Alexander Lerner; Vishal Patel; Sandy Zhang-Nunes; Jessica ChangNANOS Annual Meeting 2023: Poster Session II: Ocular-Imaging
25 Case Report: Occult GCA Presented with Episodes of Transient Visual Loss and Subsequently Developed CRAOPitchaya AmornvararakNANOS Annual Meeting 2020: Poster Session I: Clinical Highlights
1 - 25 of 403